Determine the Efficacy of the combination treatment (cetuximab plus capecitabine and oxaliplatin) as first-line therapy based on the overall response rate (ORR) according to the RECIST criteria. [clinicaltrials_resource:0e32a5ab348958e3903920c9af148940]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Determine the Efficacy of the combination treatment (cetuximab plus capecitabine and oxaliplatin) as first-line therapy based on the overall response rate (ORR) according to the RECIST criteria. [clinicaltrials_resource:0e32a5ab348958e3903920c9af148940]
Bio2RDF identifier
0e32a5ab348958e3903920c9af148940
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:0e32a5ab348958e3903920c9af148940
measure [clinicaltrials_vocabulary:measure]
Determine the Efficacy of the ...... ording to the RECIST criteria.
identifier
clinicaltrials_resource:0e32a5ab348958e3903920c9af148940
title
Determine the Efficacy of the ...... ording to the RECIST criteria.
@en
type
label
Determine the Efficacy of the ...... 2a5ab348958e3903920c9af148940]
@en